海正药业
(600267)
| 流通市值：136.20亿 | | | 总市值：136.20亿 |
| 流通股本：11.80亿 | | | 总股本：11.80亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 4,475,493,027.22 | 2,390,467,858.12 | 10,549,640,956.88 | 7,922,794,186.82 |
| 营业总成本 | 3,759,499,912.51 | 2,063,639,937.5 | 9,450,690,106.08 | 7,073,625,021.67 |
| 其他经营收益 | | | | |
| 营业利润 | 827,843,349.74 | 483,530,067.68 | 867,036,072.98 | 642,723,665.14 |
| 利润总额 | 823,575,031.14 | 482,460,032.88 | 815,376,113.02 | 619,735,138.6 |
| 净利润 | 641,713,626.28 | 358,547,074.98 | 547,485,702.43 | 468,057,810.1 |
| 每股收益 | | | | |
| 其他综合收益 | -3,147,341.15 | -1,575,109.08 | -2,385,203.76 | -1,325,403.18 |
| 综合收益总额 | 638,566,285.13 | 356,971,965.9 | 545,100,498.67 | 466,732,406.92 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,826,179,360.01 | 4,372,732,004.77 | 5,410,579,272.98 | 5,625,281,335.1 |
| 非流动资产: | | | | |
| 非流动资产合计 | 9,748,597,291.15 | 9,440,109,923.19 | 9,640,993,012.78 | 9,692,358,629.03 |
| 资产总计 | 13,574,776,651.16 | 13,812,841,927.96 | 15,051,572,285.76 | 15,317,639,964.13 |
| 流动负债: | | | | |
| 流动负债合计 | 4,098,282,967.88 | 4,387,015,291.97 | 5,833,232,108.63 | 5,936,176,087.43 |
| 非流动负债: | | | | |
| 非流动负债合计 | 224,388,736.76 | 230,607,573.5 | 366,656,040.74 | 626,193,812.58 |
| 负债合计 | 4,322,671,704.64 | 4,617,622,865.47 | 6,199,888,149.37 | 6,562,369,900.01 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,991,625,913.17 | 8,947,924,667.12 | 8,607,245,942.92 | 8,510,481,174.57 |
| 股东权益合计 | 9,252,104,946.52 | 9,195,219,062.49 | 8,851,684,136.39 | 8,755,270,064.12 |
| 负债和股东权益合计 | 13,574,776,651.16 | 13,812,841,927.96 | 15,051,572,285.76 | 15,317,639,964.13 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 4,930,836,804.85 | 2,887,812,760.65 | 11,529,094,137.25 | 8,966,184,921.9 |
| 经营活动现金流出小计 | 4,098,802,404.45 | 2,436,984,851.04 | 9,497,418,121.83 | 7,321,521,370.83 |
| 经营活动产生的现金流量净额 | 832,034,400.4 | 450,827,909.61 | 2,031,676,015.42 | 1,644,663,551.07 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 474,087,704.36 | 470,928,796.83 | 86,239,447.53 | 75,394,098.8 |
| 投资活动现金流出小计 | 759,567,339.11 | 266,102,819.58 | 455,340,194.29 | 274,067,249.41 |
| 投资活动产生的现金流量净额 | -285,479,634.75 | 204,825,977.25 | -369,100,746.76 | -198,673,150.61 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 891,800,000 | 741,000,000 | 2,357,854,777.04 | 1,431,330,849.25 |
| 筹资活动现金流出小计 | 1,644,958,126.05 | 817,676,626.32 | 3,991,242,439.16 | 2,674,957,417.46 |
| 筹资活动产生的现金流量净额 | -753,158,126.05 | -76,676,626.32 | -1,633,387,662.12 | -1,243,626,568.21 |
| 汇率变动对现金及现金等价物的影响 | -3,846,826.12 | -1,508,819.97 | -887,015.79 | 231,228.83 |
| 现金及现金等价物净增加额 | -210,450,186.52 | 577,468,440.57 | 28,300,590.75 | 202,595,061.08 |
| 期末现金及现金等价物余额 | 1,007,734,810.94 | 1,795,653,438.03 | 1,218,184,997.46 | 1,392,479,467.78 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -210,450,186.52 | - | 28,300,590.75 | - |